|
Volumn 741, Issue 2, 2000, Pages 129-144
|
Gemfibrozil and its oxidative metabolites: Quantification of aglycones, acyl glucuronides, and covalent adducts in samples from preclinical and clinical kinetic studies
|
Author keywords
Acyl glucuronides; Aglycones; Gemfibrozil
|
Indexed keywords
BUMETANIDE;
DRUG METABOLITE;
GEMFIBROZIL;
PIRETANIDE;
ACCURACY;
AEROBIC METABOLISM;
ANIMAL EXPERIMENT;
ARTICLE;
CALIBRATION;
COVALENT BOND;
DRUG BLOOD LEVEL;
DRUG DETERMINATION;
DRUG TISSUE LEVEL;
DRUG URINE LEVEL;
GLUCURONIDATION;
HUMAN;
HUMAN EXPERIMENT;
HYDROLYSIS;
HYPERLIPIDEMIA;
NONHUMAN;
PRIORITY JOURNAL;
RAT;
REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
TECHNIQUE;
TISSUE HOMOGENATE;
ANIMALS;
ANTILIPEMIC AGENTS;
CHROMATOGRAPHY, HIGH PRESSURE LIQUID;
GEMFIBROZIL;
GLUCURONIDES;
HUMANS;
HYPERLIPIDEMIAS;
RATS;
REFERENCE STANDARDS;
REPRODUCIBILITY OF RESULTS;
SENSITIVITY AND SPECIFICITY;
SPECTROMETRY, FLUORESCENCE;
|
EID: 0343091510
PISSN: 13872273
EISSN: None
Source Type: Journal
DOI: 10.1016/S0378-4347(00)00041-4 Document Type: Article |
Times cited : (35)
|
References (31)
|